Isocitrat-Dehydrogenase (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Isocitrat-Dehydrogenase" in German language version.

refsWebsite

Global rank German rank

2^nd place

3^rd place

4^th place

7^th place

123^rd place

6^th place

5,849^th place

4,709^th place

3,537^th place

429^th place

68^th place

29^th place

doi.org

D. T. Hartong, M. Dange u. a.: Insights from retinitis pigmentosa into the roles of isocitrate dehydrogenases in the Krebs cycle. In: Nature genetics. Band 40, Nummer 10, Oktober 2008, S. 1230–1234, doi:10.1038/ng.223. PMID 18806796. PMC 2596605 (freier Volltext).
Christopher J. Pirozzi, Hai Yan: The implications of IDH mutations for cancer development and therapy. In: Nature Reviews Clinical Oncology. Band 18, Nr. 10, Oktober 2021, ISSN 1759-4774, S. 645–661, doi:10.1038/s41571-021-00521-0.
Petr Ježek: 2-Hydroxyglutarate in Cancer Cells. In: Antioxidants & Redox Signaling. Band 33, Nr. 13, 1. November 2020, ISSN 1523-0864, S. 903–926, doi:10.1089/ars.2019.7902, PMID 31847543, PMC 7533892 (freier Volltext).
Fu-Ju Chou, Yang Liu, Fengchao Lang, Chunzhang Yang: D-2-Hydroxyglutarate in Glioma Biology. In: Cells. Band 10, Nr. 9, 7. September 2021, ISSN 2073-4409, S. 2345, doi:10.3390/cells10092345, PMID 34571995, PMC 8464856 (freier Volltext).

D. T. Hartong, M. Dange u. a.: Insights from retinitis pigmentosa into the roles of isocitrate dehydrogenases in the Krebs cycle. In: Nature genetics. Band 40, Nummer 10, Oktober 2008, S. 1230–1234, doi:10.1038/ng.223. PMID 18806796. PMC 2596605 (freier Volltext).
Petr Ježek: 2-Hydroxyglutarate in Cancer Cells. In: Antioxidants & Redox Signaling. Band 33, Nr. 13, 1. November 2020, ISSN 1523-0864, S. 903–926, doi:10.1089/ars.2019.7902, PMID 31847543, PMC 7533892 (freier Volltext).
Fu-Ju Chou, Yang Liu, Fengchao Lang, Chunzhang Yang: D-2-Hydroxyglutarate in Glioma Biology. In: Cells. Band 10, Nr. 9, 7. September 2021, ISSN 2073-4409, S. 2345, doi:10.3390/cells10092345, PMID 34571995, PMC 8464856 (freier Volltext).

Eintrag zu 2-Hydroxy-Glutarazidurie. In: Orphanet (Datenbank für seltene Krankheiten)

Christopher J. Pirozzi, Hai Yan: The implications of IDH mutations for cancer development and therapy. In: Nature Reviews Clinical Oncology. Band 18, Nr. 10, Oktober 2021, ISSN 1759-4774, S. 645–661, doi:10.1038/s41571-021-00521-0.
Petr Ježek: 2-Hydroxyglutarate in Cancer Cells. In: Antioxidants & Redox Signaling. Band 33, Nr. 13, 1. November 2020, ISSN 1523-0864, S. 903–926, doi:10.1089/ars.2019.7902, PMID 31847543, PMC 7533892 (freier Volltext).
Fu-Ju Chou, Yang Liu, Fengchao Lang, Chunzhang Yang: D-2-Hydroxyglutarate in Glioma Biology. In: Cells. Band 10, Nr. 9, 7. September 2021, ISSN 2073-4409, S. 2345, doi:10.3390/cells10092345, PMID 34571995, PMC 8464856 (freier Volltext).